252 related articles for article (PubMed ID: 28494185)
1. Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods.
Arora S; Huwe PJ; Sikder R; Shah M; Browne AJ; Lesh R; Nicolas E; Deshpande S; Hall MJ; Dunbrack RL; Golemis EA
Cancer Biol Ther; 2017 Jul; 18(7):519-533. PubMed ID: 28494185
[TBL] [Abstract][Full Text] [Related]
2. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
[TBL] [Abstract][Full Text] [Related]
4. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
Drost M; Koppejan H; de Wind N
Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
[TBL] [Abstract][Full Text] [Related]
6. Predictive functional assay-based classification of PMS2 variants in Lynch syndrome.
Rayner E; Tiersma Y; Fortuno C; van Hees-Stuivenberg S; Drost M; Thompson B; Spurdle AB; de Wind N
Hum Mutat; 2022 Sep; 43(9):1249-1258. PubMed ID: 35451539
[TBL] [Abstract][Full Text] [Related]
7. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
[TBL] [Abstract][Full Text] [Related]
8. A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance-functional analysis reveals the pathogenic one.
Kantelinen J; Hansen TV; Kansikas M; Krogh LN; Korhonen MK; Ollila S; Nyström M; Gerdes AM; Kariola R
Fam Cancer; 2011 Sep; 10(3):515-20. PubMed ID: 21431882
[TBL] [Abstract][Full Text] [Related]
9. Tumour characteristics provide evidence for germline mismatch repair missense variant pathogenicity.
Li S; Qian D; Thompson BA; Gutierrez S; Wu S; Pesaran T; LaDuca H; Lu HM; Chao EC; Black MH
J Med Genet; 2020 Jan; 57(1):62-69. PubMed ID: 31391288
[TBL] [Abstract][Full Text] [Related]
10. Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
Houlleberghs H; Dekker M; Lantermans H; Kleinendorst R; Dubbink HJ; Hofstra RM; Verhoef S; Te Riele H
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4128-33. PubMed ID: 26951660
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive functional assessment of MLH1 variants of unknown significance.
Borràs E; Pineda M; Brieger A; Hinrichsen I; Gómez C; Navarro M; Balmaña J; Ramón y Cajal T; Torres A; Brunet J; Blanco I; Plotz G; Lázaro C; Capellá G
Hum Mutat; 2012 Nov; 33(11):1576-88. PubMed ID: 22736432
[TBL] [Abstract][Full Text] [Related]
12. Verification of the three-step model in assessing the pathogenicity of mismatch repair gene variants.
Kansikas M; Kariola R; Nyström M
Hum Mutat; 2011 Jan; 32(1):107-15. PubMed ID: 21120944
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and structural characterization of two variants of uncertain significance in the PMS2 gene.
D'Arcy BM; Blount J; Prakash A
Hum Mutat; 2019 Apr; 40(4):458-471. PubMed ID: 30653781
[TBL] [Abstract][Full Text] [Related]
14. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
[TBL] [Abstract][Full Text] [Related]
15. Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells.
Rath A; Mishra A; Ferreira VD; Hu C; Omerza G; Kelly K; Hesse A; Reddi HV; Grady JP; Heinen CD
Hum Mutat; 2019 Nov; 40(11):2044-2056. PubMed ID: 31237724
[TBL] [Abstract][Full Text] [Related]
16. CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein.
Terui H; Akagi K; Kawame H; Yura K
J Biomed Sci; 2013 Apr; 20(1):25. PubMed ID: 23621914
[TBL] [Abstract][Full Text] [Related]
17. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome.
Wielders E; Delzenne-Goette E; Dekker R; van der Valk M; Te Riele H
Fam Cancer; 2017 Apr; 16(2):221-229. PubMed ID: 27873144
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
19. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).
Chao EC; Velasquez JL; Witherspoon MS; Rozek LS; Peel D; Ng P; Gruber SB; Watson P; Rennert G; Anton-Culver H; Lynch H; Lipkin SM
Hum Mutat; 2008 Jun; 29(6):852-60. PubMed ID: 18383312
[TBL] [Abstract][Full Text] [Related]
20. Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity.
Houlleberghs H; Goverde A; Lusseveld J; Dekker M; Bruno MJ; Menko FH; Mensenkamp AR; Spaander MCW; Wagner A; Hofstra RMW; Te Riele H
PLoS Genet; 2017 May; 13(5):e1006765. PubMed ID: 28531214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
